Call for Abstract

2nd European Cardiology Congress, will be organized around the theme “Covid-19 challenges for Technological and Clinical Advances in Cardiology”

Euro Cardiology Congress 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Cardiology Congress 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Congenital heart defect, it means that children born with a problem in the structure of his or her heart. Some congenital heart defects in children are simple and don't need treatment. Other congenital heart defects in children are more complex and may require several surgeries performed over a period of several years. There are many different types of congenital heart defects:

  • Holes in the heart
  • Obstructed blood flow
  • Abnormal blood vessels
  • Heart valve abnormalities
  • An underdeveloped heart
  • A combination of defects

Cardiologists, cardiac surgeons and pediatric cardiovascular specialists are welcome to share their experience and research to advance the cutting-edge diagnostic and surgical techniques.

  • Track 1-1Atrial Septal Defect
  • Track 1-2Atrioventricular Canal Defect
  • Track 1-3Ebstein’s Anomaly
  • Track 1-4Hypoplastic Left Heart Syndrome
  • Track 1-5Interrupted Aortic Arch
  • Track 1-6Pulmonary Stenosis and Atresia
  • Track 1-7Transposition of the Great Arteries
  • Track 1-8Ventricular Septal Defect

Cardiovascular disease (CVD) is the leading cause of death in many developed countries and remains one of the major diseases strongly affected by the diet. Nutrition can affect CVD directly by contributing to the accumulation of vascular plaques and indirectly by regulating the rate of aging. Consumption of ultra-processed foods worldwide has increased substantially, studies have shown that higher consumption of ultra-processed foods was associated with higher risks of cardiovascular, coronary heart, and cerebrovascular diseases. Recent study found that eating more plant-based foods reduces the risk of heart failure by 40%, while another one found that a vegetarian diet cuts the risk of heart disease death.

Researchers are welcome to present their observation and advice which can reduce risk and preventive factors in the development and prevention of CVD.

  • Track 2-1Dietary Cholesterol intake
  • Track 2-2Obesity associated with cardiovascular disease
  • Track 2-3Atherosclerosis and Hypertension affected by diet
  • Track 2-4Nutrients and their impact on cardiovascular disease

Scientific, educational and CVI professionals including cardiologists, cardiovascular radiologists, sonographers, imaging cardiologists, nuclear medicine physicians, pulmonologists, internists, cardiothoracic surgeons, pathologists and nurses are pleased to contribute their knowledge and research to promote and develop advance research and clinical practice of Cardiovascular Imaging, helping to improve the standardization of CVI practice.

It includes magnetic resonance imaging, computed tomography, X-ray imaging, interventional imaging, applications in nuclear cardiology and echocardiography, and any combination of these techniques. Clinical applications of such imaging techniques include improved diagnostic approaches, treatment and prognosis.

  • Track 3-1Echocardiography
  • Track 3-2Magnetic resonance imaging (MRI)
  • Track 3-3Computed tomography (CT)
  • Track 3-4 Nuclear medicine imaging
  • Track 3-5Coronary catheterization
  • Track 3-6 Intravascular ultrasound

Valvular Heart Disease is now at the center of developments in Cardiovascular Medicine and Surgery, it is a pathological condition affecting one or more of the heart valves, elevated blood pressure is a well-known risk factor. In valvular heart disease, we don’t really have treatment outside of changing the valves, or repairing the valves, which is very expensive and too late in the disease process.

So, individuals involved in the research who wish to present their observation are welcome to help understand the future developments and ideas to prevent this from happening.

  • Track 4-1Aortic and mitral valve disorders
  • Track 4-2Pulmonary and tricuspid valve disorders
  • Track 4-3Aortic stenosis and Mitral stenosis
  • Track 4-4Calcific disease
  • Track 4-5 Dysplasia

Also known as coronary artery disease, one of the leading causes of death worldwide, forms plaque in the walls of the arteries that supply blood to the heart. A complete blockage of these arteries can lead to a heart attack or stroke. Further, studies have shown that many genes contributing to the genetics of coronary artery disease affect mechanisms that were not expected. Join us with your group to explore the novel insights on how to prevent its development. Also know:

  • Pathophysiology of Coronary Artery Disease
  • Coronary Artery Disease Angina
  • Coronary Artery Disease Risk Factors, Preventions and Treatment
  • Coronary Artery Disease and Omega-3 Fatty Acids
  • Track 5-1Coronary heart disease causes and development
  • Track 5-2Coronary heart disease risk in women
  • Track 5-3Risk factors of coronary heart disease
  • Track 5-4New treatment options for coronary artery disease
  • Track 5-5Effective lifestyle- Secondary prevention
  • Track 5-6Pathophysiology- lack of oxygen

Cardiac remodeling is defined as molecular and interstitial changes, manifested clinically by changes in size, mass, geometry and function of the heart under the stressful condition. Myocardial infarction and/or acute ischemia provoke profound changes in the properties of cardiac muscle. The response of the heart to sustained load increases, as in hypertension and aortic stenosis, results in an increase in muscle mass in overloaded chamber. We have included the session to help researchers in evaluating the different factors of cardiac remodeling and to further explore the underlying mechanism seeking the optimal therapeutic targets. Authors are welcome to submit experimental research articles. Topics of interest includes:

  • Cardiac Remodeling after Myocardial Infarction
  • Cardiac Remodeling in Hypertension
  • Cardiac remodeling in metabolic syndrome
  • Cardiac Remodeling in Heart Failure
  • Cardiac Remodeling in ischemia
  • Cardiac Remodeling in ventricular dysfunction
  • Cardiac Remodeling and Endothelial Function
  • Cardiac Remodeling in valve diseases
  • Blood vessels and perivascular fibrosis
  • Track 6-1Clinical Implications
  • Track 6-2Pathophysiological Mechanisms of Cardiac Dysfunction
  • Track 6-3Myocardial infarction complications
  • Track 6-4Pharmacological Treatment
  • Track 6-5Arrhythmias

It is the process to understand the complexity of disease, injury and abnormalities. The rising demand for efficient and rapid diagnostics of cardiovascular diseases, Cardiac Biomarker Testing is leading the market and expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period. Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. The other diagnostic tests that are being used to further understand and identify cardiovascular disease are:

  • Electrocardiogram
  • Echocardiogram
  • Coronary Arteriogram
  • Positron Emission Tomography
  • Thallium Scans or Myocardial Perfusion Scans
  • Electrophysiology Study
  • Cardiac Catheterization
  • Troponin-blood test

Troponin blood tests are widely used to help physicians detect heart attacks, test looks at a protein that comes directly from the heart and is found at elevated levels in the blood after heart muscle has been injured. As healthcare systems make a shift from treating symptoms of heart disease to preventing the onset of it, research now indicates that measuring a person's troponin levels using Abbott's High Sensitive Troponin-I blood test also can help predict a person's chances of having a cardiac event potentially years in advance when they show no signs or symptoms.

  • Track 7-1Electrocardiogram
  • Track 7-2Stress test
  • Track 7-3Transthoracic echocardiogram
  • Track 7-4Positron emission tomography (PET) scan
  • Track 7-5Thallium scans or myocardial perfusion scans
  • Track 7-6Holter monitor
  • Track 7-7Electrophysiology study
  • Track 7-8MRI of the heart
  • Track 7-9Cardiac CT scan

Cardiometabolic health encompasses cardiovascular and metabolic diseases, including type 2 diabetes and metabolic syndrome. The risk factors include overweight/obesity, elevated blood pressure which can be modified by diet and lifestyle choices. Obesity which is a major factor of heart failure. This is a serious condition when your heart cannot pump enough blood to satisfy the needs of your body, a person is at increased risk of heart disease and stroke. One can reduce the risk by maintaining blood glucose levels, blood pressure and blood cholesterol levels. Stroke and coronary heart disease can be caused by the same problem - atherosclerosis.

The scientific goal of this track is to understand the underlying causes and pathophysiology of obesity, diabetes, and associated metabolic diseases, as well as pursuing effective and safe interventions and therapeutics.

  • Track 8-1Cardiac complications of diabetes and obesity
  • Track 8-2Metabolic health
  • Track 8-3Endocrinal and Hormonal Obesity
  • Track 8-4Metabolic derangements associated with obesity

Cardiothoracic surgeons, cardiothoracic anesthesiologists, cardiologists, chest physicians, and allied health professionals are pleased to present their clinical and experimental advances in cardiac and thoracic surgery ensuring the best possible outcomes.

Topics of interest include surgical techniques, survival rates, surgical complications and their outcomes, pediatric conditions, Robotic and minimally invasive cardiac surgery, transplantations and clinical trials.

  • Track 9-1Congenital cardiac surgery
  • Track 9-2Adult cardiac surgery
  • Track 9-3General thoracic surgery
  • Track 9-4Heart and lung transplant surgery
  • Track 9-5Risks of cardiac surgery

The aim of this scientific session is clearly understanding the mechanism for cardiac toxicity and risk factors. The emergence of various targeted anticancer agents has led cardiotoxic potential. Cardiovascular complication from cancer therapy include heart failure, coronary artery disease, arrhythmias, QT prolongation, valvular disease, arterial hypertension, thromboembolic disease, and peripheral vascular disease. The field of cardiotoxicity induced by targeted drugs is rapidly expanding leading to the evolution of a new subspecialty of cardio-oncology to deal with the new health burden. Heart failure is one of the most dramatic clinical expressions of cardiotoxicity, and it may occur acutely or appear years after treatment. It is imperative for an oncologist to know the toxicity profile of newer agents to lower the risk against the benefit of these agents.

  • Track 10-1Causes of cardiac toxicity
  • Track 10-2Clinical symptoms of cardiac toxicity
  • Track 10-3Treatment of cardiac toxicity
  • Track 10-4Types of cardiac injury

MRI can be used to measure how the heart uses oxygen for both healthy patients and those with heart disease. Currently, the diagnostic tests available to measure blood flow to the heart require injection of radioactive chemicals or contrast agents that change the MRI signal and detect the presence of disease.

We would like to welcome the researchers to bring out the new advance methods where MRI does not require needles and chemicals being injected into the body.

Cardiac nuclear medicine is useful in diagnosing and assessing coronary artery disease. It is also used to evaluate cardiomyopathy and identify possible damage to the heart from chemotherapy or radiotherapy. Nuclear medicine examinations provide unique information including details on the function and anatomy of structures that is often unattainable using other imaging procedures. Nuclear medicine procedures can be time consuming. It can take several hours to days for the radiotracer to accumulate in the area of interest, and imaging may take up to several hours to perform.

Further, Cardiovascular computed tomography (CCT) is a proven clinical utility in the diagnosis and management of coronary artery disease, in guiding structural heart disease intervention, and in the diagnosis and treatment of congenital heart disease.

As we know technology is changing rapidly in the field of healthcare leading to advancement in the diagnosis and treatment of patients with possible cardiovascular disease, our aim is to bring together experts to provide interactive session and networking.

  • Track 11-1 Advanced imaging modalities
  • Track 11-2Noninvasive procedures- benefits vs Risks

Nanomedicine uses the nanotechnology in manipulating materials, structures and devices at the molecular level to diagnose, treat, cure damaged tissue or disease and to develop effective, therapeutic nanomedicine

Session goal will be an inventive and fortifying International gathering of Neonatologists, Pediatricians and Cardiologist to Share the Research Updates and enhance collaboration amongst members for scientific research and professional development and to maintain high standards of professional practices on Pediatrics and Cardiology, Cardiac Care.

  • Track 12-1Clinical applications in diagnostics, drug therapy and regenerative medicine
  • Track 12-2Nanosurgery
  • Track 12-3Effective therapeutic nanomedicine

Euro Cardiology Congress 2020 intended to provide cardiology case reports for new developments in methodology and techniques featuring novel findings. This session is open to all the clinical cases such as various areas of heart related issues, cardiovascular medicine, cardiovascular diseases, myocardial infraction, atrial fibrillation, valvular heart diseases, cardiomyopathy, heart failure, coronary artery diseases, atherosclerosis, arrhythmias, angina, congenital heart diseases, pericardial disease, vascular diseases, hypertension, peripheral arterial disease, heart defects, pediatric cardiology, echocardiography, heart surgery and treatment.

  • Track 13-1Important clinical cases of recent occurrence
  • Track 13-2Rare medical cases and conditions
  • Track 13-3Latest methods of examination

Disorders characterized by structural and functional abnormalities of the myocardium. This group of pathological conditions includes dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and left ventricular noncompaction cardiomyopathy. All cardiomyopathies cause premature death from arrhythmia and progressive heart failure.

Interested researchers are welcome to submit their abstract aiming to contribute the important future research goals for precision medicine and individualized effective treatment.

  • Track 14-1Possible causes of myocarditis- viral and bacterial infection
  • Track 14-2Hypertrophic obstructive cardiomyopathy
  • Track 14-3Inflammation of the heart muscle wall
  • Track 14-4Restrictive cardiomyopathy
  • Track 14-5Cardiomyopathy
  • Track 14-6Preventive strategy for cardiomyopathy

With advances in surgical strategies and medical therapies, the outcomes for pediatric heart transplant recipients have continually improved. While significant post-transplant complications like rejection, infection, malignancy, and heart transplant remains a therapeutic option to improve both the quality and quantity of life for pediatric patients.

We are pleased to invite pediatric cardiac transplant surgeons and transplant cardiologists to help the young researchers advancing the understanding and management of Pediatric Heart Transplantation that will benefit both today's patients and transplant patients in the future.

  • Track 15-1Risk factors for mortality in Pediatric Heart Transplantation
  • Track 15-2Current state of pediatric heart transplantation
  • Track 15-3Changing indications of Heart Transplantation
  • Track 15-4Alternative therapies and challenges

The pharmacological study that deals with Cardiac and Neuronal drugs. Cardiac or Cardiovascular pharmacology reveals the cardiac medicine activities in different heart diseases that include cardiac arrhythmias, hypertension, congestive heart failure, Angina and cardiomyopathy. The neuronal pharmacology concentrates on neurological disorders and their drug pharmacological activities. There is a physiological relation between these cardiac and neuropharmacology because almost every cardiac disorder is inter-dependent on the nervous system. The cardiac system is internally being controlled by sympathetic and parasympathetic nervous systems.


  1. Renin-Angiotensin-Aldosterone System
  2. Neural Control on Cardiovascular System
  3. Cardiovascular Drugs
  4. Pharmacokinetics
  5. Drug-Drug and Drug-Food Interactions
  6. Neurochemical Interactions
  7. Molecular and Behavioural Neuropharmacology
  • Track 16-1Pharmacotherapy for Cardiac Arrhythmias
  • Track 16-2Anti-Ischemic Drug Therapy
  • Track 16-3Drug Therapy for Systemic Hypertension
  • Track 16-4Pharmacotherapy for Acute and Chronic Heart Failure

It involves the study of molecular mechanisms of common cardiovascular diseases including heart attack, stroke, heart failure, and high blood pressure then translates these discoveries into new clinical strategies for diagnosis and therapy. As an emerging discipline, it has changed our conceptual thinking of cardiovascular development, disease etiology, and pathophysiology.

  • Track 17-1Important discoveries that uncover the causes of congenital and acquired problems
  • Track 17-2 Techniques for the mechanistic investigation and diagnosis
  • Track 17-3Transgenic techniques in cardiac research

Research on prevention to diagnosis and treatment, the ongoing research includes pioneering the use of heart scanning in the early diagnosis of heart disease, development of Nuclear Cardiology techniques for the detection of heart disease, Drug development and evaluation of treatments used in heart disease, Identification of novel biological markers to predict the presence of heart disease, Analysis of ethnic and socio-economic differences in heart disease risk.

  • Track 18-1New molecular approach to advancing cardiovascular therapy
  • Track 18-2Will Artificial intelligence advance the cardiovascular field?
  • Track 18-3Major technological advances in bioengineering in cardiology
  • Track 18-4Novel drug discovery/development
  • Track 18-5Role of electronics and digital technology

Cardiovascular implications of cancer therapy have led to the development of Cardio-Oncology which focuses on diagnosing, preventing and treating these complications. While a major focus of chemotherapy-related cardiac dysfunction has been on left ventricular ejection fraction, oncologic treatment can lead to cardiovascular pathology in a variety of ways. The use of multimodality imaging is essential to the care of these patients, with nuclear cardiology playing an important role.

Cardiologists, cardiac imaging specialists, cardio-oncologists and oncologists are welcome to submit their research providing understanding on how nuclear cardiac imaging may be used in the diagnosis, prevention and management of cardiovascular implications of cancer therapy.

  • Track 19-1Development of new anti-cancer drugs
  • Track 19-2Modern oncologic therapies
  • Track 19-3Novel molecular markers of pre-clinical cardiotoxicity
  • Track 19-4Latest in nuclear cardiology

Cardiac nursing is a specialty focused on preventing and treating conditions, also an understanding of normal cardiac anatomy and physiology, keen assessment and monitoring skills, vast knowledge about cardiac disease and conditions, and ongoing education related to recommended prevention methods and treatment options. Clinical nurse specialists and nurse practitioners provides the comprehensive cardiovascular care for patients with acute and chronic heart. Major areas include:

Management of Cardiac Patients in Critical Care and Acute Care, Advanced Health Assessment, Clinical Prevention and Advanced Pathophysiology.

  • Track 20-1Discussion on the involvement of nurses in achieving an effective heart failure service
  • Track 20-2Management of Cardiac Patients in Critical Care and Acute Care
  • Track 20-3Increase patient awareness and education of the condition and current management
  • Track 20-4Advanced Health Assessment

The main goal is to understand the cause of dyslipidemia and primary prevention which can lead to heart and vascular problems such as heart attack, stroke and reduced circulation. To identify and reduce their risk factors through customized medical management, as well as nutrition and exercise counseling. Thus, the new era demands a more efficient and comprehensive approach to risk assessment and treatment with the mandate to detect and treat disease well before it becomes clinically apparent.

  • Track 21-1Treatment plan to reduce the risk of cardiovascular events
  • Track 21-2Lipid research-implementing biochemical and molecular diagnosis techniques
  • Track 21-3Particularly severe or difficult to control elevations in cholesterol
  • Track 21-4Assessment of individual risk and early initiation

Hypertension is the disorder where the blood pressure in the arteries is persistently raised at a constant rate. This is also called as high blood pressure or high vital sign or blood vessel cardiovascular disease. It can lead to severe health complications and increase the risk of heart disease, stroke, and sometimes death. This session primarily covers the various sorts of cardiovascular disease and their evaluation. Almost 90-95 % of cases are primary and the main cause behind it is the unhealthy lifestyle followed by excessive consumption of alcohol, salt, body weight etc. Remaining 5-10% of individuals suffer this due to thinning of kidney arteries, chronic kidney diseases, and endocrine disorder.  Assessment of cardiovascular disease primarily includes Confirmation of hypertension, Risk factors, Fundamental causes, organ injury & Indications and contraindications of medication. Hypertension could be a major threat issue for cardiopathy and stroke.

  • Track 22-1Hypertensive Heart Disease
  • Track 22-2Causative Factors and Risk Assessment
  • Track 22-3Causes of Cardiac Arrest Due to Hypertension
  • Track 22-4Advanced Treatment Approaches
  • Track 22-5Hypertension – Stress and Stroke

It offers academic and industrial investigators a forum for the dissemination of research that utilizes engineering principles and methods to advance fundamental knowledge and technological solutions related to the cardiovascular system. Developing novel diagnostic and therapeutic approaches for cardiovascular diseases.

  • Track 23-1Advance implantable medical devices
  • Track 23-2Hemodynamics and tissue biomechanics
  • Track 23-3Functional imaging and surgical devices
  • Track 23-4Tissue engineering and regenerative medicine

It deals with the treatment of structural heart diseases with the catheter-based treatment. Cardiac catheterization is a procedure to examine heart muscle, valves or coronary (heart) arteries. A thin, hollow tube called a catheter is inserted into a large blood vessel that leads to your heart. Some heart disease treatments, such as coronary angioplasty and coronary stenting are done using cardiac catheterization. The main advantages of using the interventional cardiology or radiology approach are the avoidance of the scars and pain, and long post-operative recovery.

  • Track 24-1Current research on effective procedures
  • Track 24-2Risks of cardiac catheterization

Involves the clinical conditions that involves both heart and kidney. Understanding the latest findings regarding epidemiology and pathophysiology of combined heart and kidney diseases is the main goal of conference. Clinicians, researchers, and trainees in the fields of nephrology, cardiology, internal medicine and its subspecialties, hospital medicine, family medicine, pediatrics, emergency medicine, pulmonary and critical care medicine, geriatrics and anesthesiology, physicians and scientists, nurse practitioners and physician assistants are welcome to attend the conference.

  • Track 25-1Pulmonary Hypertension in Chronic Kidney Disease
  • Track 25-2Overview and Update on Uric Acid and Hyperuricemia

Clinically used to monitor the electrical activity of the heart over time via electrodes placed on the skin of the chest. The method can identify aberrant activity caused by heart conditions, prime function in screening and diagnosis of cardiovascular diseases for better understanding, diagnosis, and treatment of cardiac diseases such as arrhythmias, altered activations, and ischemia.

  • Track 26-1Application of ECG diagnoses
  • Track 26-2Signal-averaged electrocardiogram
  • Track 26-3Transthoracic echocardiography

Cardiac surgery is the procedure performed on the heart or great vessels by cardiac surgeons. It is often used to treat complications of ischemic heart, to correct congenital heart disease; or to treat valvular heart disease from various causes, including endocarditis, rheumatic heart disease, and atherosclerosis. It also includes heart transplantation. The future of cardiac surgery hinges on the surgeon's ability to improve techniques, innovate in therapies, and diversify practice.

  • Track 27-1Minimally Invasive Coronary Artery Bypass Surgery
  • Track 27-2Trans myocardial Laser Revascularization
  • Track 27-3Valve-Sparing Aortic Root Replacement

Cardiac regeneration is a broad effort that aims to repair irreversibly damaged heart tissue with new therapeutic applications including stem cell and cell-free therapy. Stem cells are undifferentiated cells which can develop into cells that serve numerous functions in different parts of the body. Since stem cells have the ability to turn into various other types of cells, scientists believe that they can be useful for treating and understanding diseases. Therefore, stem cell therapy could be a promising therapeutic approach for the treatment of cardiovascular diseases.

  • Track 28-1Novel Strategies for Stem Cell-Based Therapies
  • Track 28-2Embryonic cardiomyogenesis
  • Track 28-3Cardiac regenerative medicine
  • Track 28-4Cell-based regenerative therapies

It deals with the anesthesia aspects of care related to surgical cases such as open heart surgery, lung surgery, and other operations of the human chest. These aspects include perioperative care with expert manipulation of patient cardiopulmonary physiology through precise and advanced application of pharmacology, resuscitative techniques, critical care medicine, and invasive procedures. This also includes management of the cardiopulmonary bypass (heart-lung) machine, which most cardiac procedures require intraoperatively while the heart undergoes surgical correction. A cardiovascular anesthesiologist is a physician who specializes in providing anesthesia care for patients undergoing either cardiac (heart), thoracic (lungs) or vascular (blood vessels) surgery. Join us to acknowledge the overall importance of cardiovascular anesthesia.

  • Track 29-1Advanced monitoring and invasive techniques
  • Track 29-2Anaesthesia for Robotic Cardiac Surgery
  • Track 29-3Cardio-pulmonary bypass